Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep884 | Reproductive and Developmental Endocrinology | ECE2022

Obese patients with PCOS and prediabetes: two years follow up of the effects of metformin, pioglitazone and empagliflozin treatment on metabolic control, hormonal imbalance and ovulations

Ilic Nevena , Pasquali Corrado , Culafic-Vojinovic Violeta , Eror Tatjana , Zivkovic Stanislava

Introduction: The role of metformin in PCOS is very well known and several studies reported effects of thiazolidinediones and SGLT2 inhibitors on metabolic parametars in these patients.Objective: The aim of this study was to compare the effects of metformin, pioglitazone and empagliflozin treatment on metabolic control, hormonal imbalance, weight loss and ovulations in obese patients with PCOS and prediabetes.Methods: BMI, waist ci...